Download presentation
Presentation is loading. Please wait.
Published byWilliam Norris Modified over 8 years ago
1
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 21. Leukocytic disorders
2
2 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Introduction O Quantitative disorders: leukocytosis, leukopenia O Qualitative disorders: functional defects, leukemia Quantitative disorder 1. Leukocytosis (vs Leukemoid reaction) O Leukocytosis: an increase in leukocyte count O Physiological leukocytosis: at birth O Factors affecting leukocyte concentration in peripheral blood - Bone marrow production and release of leukocytes - Rate of leukocyte egress to tissue or survival time in blood - Ratio of marginating to circulating pools in peripheral blood
3
3 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE
4
4 Nonmalignant Granulocyte and Monocyte Disorders (1) Neutrophilia O An increase in the total circulating absolute neutrophil concentration O Immediate neutrophilia - A simple redistribution of the marginating pool to the circulating pool (50:50) O Acute neutrophilia - From an increase in the flow of neutrophils from the BM storage to the blood O Chronic neutrophilia - Mitotic pool -> increase production 1) Conditions associated with neutrophilia O Total leukocytes: less than 50 X 10 9 /L O increase of band and mature neutrophil O shift to the left O Toxic changes: toxic granulation, Dohle bodies, vacuoles reactive transient changes accompanying infectious state
5
5 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE O bacterial infection (vs viral infection: lymphocytosis) - endotoxin: increase in the flow of neutrophils from BM to blood * typhoid: decreased neutrophils (endotoxin: destruction of neutrophils) O tissue necrosis, inflammation O malignant tumor: tumor cell -> production of CSF O chronic myeloproliferative disorders (fully differentiation) - chronic myelogenous leukemia (CML) - polycythemia vera - essential thrombocytosis - myelofibrosis O drugs/hormone - Adrenal cortex hormone: increased flow of neutrophils from BM to blood - Corticosteroid: increased BM output and decreased migration to the tissue - Epinephrine: marginal pool -> circulating pool - Heavy metal poisoning (lead, mercury) O physiological increase: exercise, stress, epinephrine, pregnancy, newborn O acute hemolysis and acute hemorrhage
6
6 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE (2) Eosinophilia O An increase in the total circulating absolute eosinophil concentration O parasitic infection, O allergy reaction (asthma) O chronic myeloproliferative disorders - chronic myelogenous leukemia (CML) O respiratory tract, skin/connective tissue disorders (3) basophilia O An increase in the total circulating absolute basophil concentration O allergy reaction O chronic myeloproliferative disorders - chronic myelogenous leukemia (CML), polycythemia vera (4) monocytosis O An increase in the total circulating absolute monocyte concentration O inflammation, tuberculosis, neutropenia, sepsis, syphilis (5) lymphocytosis O An increase in the total circulating absolute lymphocyte concentration O virus infection (infectious mononucleosis) O increased reactive lymphocyte - large with irregular shapes and cytoplasmic basophilia, granules, vacuoles O Lymphadenopathy, splenomegaly O T cell (60-80%) vs B cell (20-40%) in peripheral blood
7
7 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE 2. Leukemoid reaction O A benign leukocyte proliferation characterized by a increased leukocyte count with many circulating immature leukocyte precursors O Seen in chronic infection, carcinoma, inflammatory processes O Indistinguishable from that of chronic myelogenous leukemia (CML)
8
8 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE 3. Infectious mononucleosis O cause: Epstein Barr virus (EBV) infection O pathophysiology - EBV -> B cell infection -> B cell activation (expression of growth factor receptor) -> increased proliferation - by increased cytotoxic T cell (reactive lymphocyte) -> Inhibit the activation and proliferation of EBV-infected B cells O Clinical findings O Fever, pharyngitis, lymphadenopathy, splenomegaly (Table 20-2) O Laboratory findings - PBS: RBC count: normal, thrombocytopnea lymphocytosis (increased reactive lymphocyte) vs Leukemia: lower N:C ratio, morphologic hetergeneity - Serologic tests increased transient heterophile anti-sheep RBC Ab Ab specific for EBV EBV nuclear antigen (EBNA)
9
9 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE 4. Leuko(cyto)penia: a decrease in leukocyte count (1) neutropenia 1) Decreased bone marrow production O Myeloid hypoplasia, the M:E ratio -> decrease, shift to the left O anemia (pancytopenia): aplastic anemia, megaloblastic anemia, paroxysmal nocturnal hemoglobinuria O myelodysplastic syndrome O bone marrow hypoplasia by ionizing radiation, benzene, chemotherapy drug O myelophthisis - acute leukemia, multiple myeloma: tumor in bone marrow O Congenital (hereditary) neutropenia 2) Increased cell loss: increased egress to the tissue, increased destruction O As the result of increased neutrophil diapedesis O In severe infection (cf. typhoid, viral infection) O Immune-mediated neutropenia - Alloimmune neutropenia: neonatal, transfusion reaction - Autoimmune neutropenia: systemic lupus erythematosus(SLE) O Hypersplenism (Banti syndrome), splenomegaly - increased blood cell destruction in spleen (pancytopenia) 3) Increased neutrophilic margination O Produced by alterations in the circulating and marginated pools
10
10 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE (2) Eosinopenia O Cushing’s syndrome, adrenal cortex hormone, stress O Glucocorticoid and epinephrine -> inhibit eosinophil release from the BM and increase margination (3) lymphocytopenia O results from - malignant lymphoma - Corticosteroid therapy: by sequestration of lymphocytes in the bone marrow - SLE: by autoantibodies against lymphocyte O Result in immunodeficiency (4) pancytopenia
11
11 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE 5. Immunodeficiency disorders O By impaired function of the immune system -> inability to mount a normal adaptive immune response -> increase in infections and neoplasm (1) Acquired immune deficiency syndrome (AIDS) O HIV-1 -> infect helper T cell by binding to the CD4 -> cytolysis -> lymphocytopenia -> abnormal immunity - Monocyte/macrophage: have the CD4 -> infected, not destroyed O Occurrence of repeated infections, increase in malignancies (Kaposi’s sarcoma) O Laboratory findings O Disease monitoring - CD4 lymphocyte count, plasma HIV-1 RNA copy number (viral load) - Normal CD4:CD8 in peripheral blood 2:1 -> decrease
12
12 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Nonmalignant Lymphocyte Disorders (2) Congenital immune deficiency disorders 1) Severe combined immunodeficiency syndrome (SCID) O quantitative and or qualitative immune defects - Lymphopenia or functionally deficient O T and B cell: affected 2) Wiskott-Aldrich syndrome (WAS) O Eczema, thrombocytopenia, immunodeficiency -> recurrent infections, bleeding O T (CD8) cell: affected 3) DiGeorge syndrome O Congenital immunodeficiency, heart defect, dysmorphic facies O Absence or hypoplasia of the thymus: decrease in peripheral blood T cells 4) Sex-linked agammaglobulinemia (Bruton’s disease) O Block B cell maturation -> serum Ig: decrease O Cell-mediated immunity: normal 5) Ataxia-Telangiectasia O defects in the repair of DNA double-stranded breaks O Neurologic disease, immune dysfunction, predisposition to malignancy O Defect in cell-mediated immunity, abnormal B cell function
13
13 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Quantitative disorder O congenital, abnormal function - defects in migration, phagocytosis, antimicrobial activity -> increased infection 1. Chronic granulomatous disease (CGD) O defects in bactericidal activity (the respiratory burst oxidase system) O can not generate antimicrobial oxygen metabolites (reactive oxygen species) O Can phagocytize the microorganisms but cannot kill them O Granuloma formation 2. Myeloperoxidase deficiency O Characterized by an absence of meyloperoxidase in neutrophils and monocytes O defects in hydrogen peroxide (H 2 O 2 ) production -> decreased antimicrobial activity - Cells are able to utilize an alternative system to kill the microorganism O myeloperoxidase staining: negative - caution: when differentiate between myeloblast and lymphoblast 3. Chediak-Higashi (-steinbrink) syndrome O abnormal lysosome -> defects in phagolysosome formation and degranulation -> defects in bactericidal activity and migration
14
14 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Nonmalignant Granulocyte and Monocyte Disorders 4. Lazy leukocyte syndrome O defects in migration -> decreased flow of leukocytes from the BM to the blood -> decreased leukocytes in the PB 5. Leukocyte adhesion deficiency (LAD) O Characterized by decreased or absent leukocyte adhesion protein (β 2 -integrin) O Cannot adhere to EC of the blood vessel walls and exit the circulation O Persistent leukocytosis and granulocytosis due to increased stimulation of BM
15
15 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE 6. Lysosomal storage disease O Defects in any of the lysosomal enzymes -> accumulation of partially degraded insoluble substrates (mucopolysaccharides) O autosomal recessive, affect infants and young children O hepatosplenomegaly, neuronal damage, cellular dysfunction by abnormal macrophage activation and release of cytokines (1) Gaucher disease O by deficiency of β-glucocerebrosidase (cleave glucose from ceramide) -> glucocerebroside accumulation O Macrophage: unable to digest the stroma of ingested cells O splenomegaly (pancytopenia), hepatomegaly, bone pain O Gaucher cell (Figure 19-15) - histiocyte (tissue macrophage) - Small eccentric nuclei, cytoplasm -> wrinkled tissue paper (fine folding) - PAS, Sudan Black B, acid phosphatase staining: positive O serum acid phosphatase activity: increase
16
16 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE
17
17 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE
18
18 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE
19
19 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE (2) Niemann-Pick disease O by deficiency of sphingomyelinase -> spingomyelin (phosphocholine + ceramide) accumulation O Begin in infancy with poor physical development O splenomegaly (pancytopenia), hepatomeglay, neuropathy O Foam cell (Niemann-Pick’s cell) - macrophage - Large (20-100 um) with small eccentric nuclei and cytoplasmic lipid droplet (3) Tay-Sachs disease (G M2 gangliosidosis) O hexosaminidase A deficiency -> G M2 ganglioside accumulation O CNS (brain), eye (retina) O foam cell, vacuolated histiocyte - whorled configuration within lysosome (4) Mucopolysaccharidoses (MPSs) O MPS degradative enzyme deficiency -> MPS accumulation O coarse facial feature, joint stiffness, cardiac complication, mental retardation O Hunter’s syndrome, Hurler’s syndrome
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.